GBA Presents: THE GREEN MARKET


Summary
  • XpresSpa has pivoted its business from an airport spa business to an airport Covid testing business.
  • XpresSpa has 99 cents a share in net balance sheet cash.
  • It earned roughly 5 cents a share in the third quarter driven largely by Covid testing at airports.
  • It is expanding this testing activity to additional airports and quarterly earnings should go up.
  • A price of $4-5 per share is reasonable and would represent nearly a tripling of the current price.
 
XSPA has a solid balance sheet with $109.9 million in cash and $5.6 million in debt, netting out to 99 cents a share (share count is 105.3 million) in net balance sheet cash. With a share price of $1.77, this means that the market is valuing XSPA's business at 78 cents a share
 
stonedinvestor said:
Summary
  • XpresSpa has pivoted its business from an airport spa business to an airport Covid testing business.
  • XpresSpa has 99 cents a share in net balance sheet cash.
  • It earned roughly 5 cents a share in the third quarter driven largely by Covid testing at airports.
  • It is expanding this testing activity to additional airports and quarterly earnings should go up.
  • A price of $4-5 per share is reasonable and would represent nearly a tripling of the current price.
More...
Did you see The Slinger today?!!!!
Up 7.5%
:thumbsup::thumbsup::thumbsup:
 
These poor people Van. You see what they are paying?

Europe is out, China rises. China makes friends with Russia.

The door is wide open fro new Nukes. <--- In France this " type " of reactor i assume is not the nifty small type we have been looking at with Rolls Royce and ABB
 
This hit $57 today. For a minute we were up alot.

VIR--------- GET IN!

Vir Biotechnology, Inc.
54.032.41(+4.67%)4:00 PM 12/16/21
Post-Market:$54.05+0.02(+0.04%)7:38 PM
 
You must log in or register to reply here.
Back
Top